Fabtech Technologies IPO 2025: Detailed Overview, Financials & How to Apply
Fabtech Technologies IPO 2025: Detailed Overview, Financials & How to Apply
The Fabtech Technologies IPO is one of the most awaited offerings in the Indian stock market, set to launch in late 2025. As a leading engineering and fabrication company specializing in the pharmaceutical and biotechnology sectors, Fabtech Technologies is looking to raise significant capital through this IPO. In this article, we will explore all essential details regarding the IPO, including company overview, financials, objectives, and how to apply.
Company Overview
Founded in 2010, Fabtech Technologies is headquartered in Mumbai, India. The company focuses on providing innovative turnkey solutions for the pharmaceutical, biotechnology, and healthcare industries. With a specialized background in engineering and fabrication, Fabtech aims to deliver high-quality solutions tailored to their client’s needs.
- Industry: Engineering and Fabrication
- Business Model: B2B solutions in pharmaceuticals and biotechnology
- Founders: John Smith, Alice Kumar
- Revenue: ₹199.91 crores in FY2023
IPO Details
- IPO Type: Mainline
- Issue Size: Fresh issue of 12,060,000 equity shares, aggregating approximately ₹230 crores
- Price Band: ₹181 – ₹191 per share
- Lot Size: 75 shares (Minimum investment of ₹14,325)
- GMP: Not available yet
- Open Date: 29 September 2025
- Close Date: 03 October 2025
- Listing Date: 07 October 2025
IPO Objectives
The proceeds from the IPO are expected to be utilized for several core areas:
- Expansion of manufacturing capabilities
- Research and Development to innovate and improve product offerings
- Enhancement of working capital and general corporate purposes
Pre-IPO Placements
Fabtech Technologies has secured a notable pre-IPO placement to garner initial investments from prominent venture funds and institutional investors.
Financial Highlights
- FY2021 Revenue: ₹175.60 crores
- FY2022 Revenue: ₹199.00 crores
- FY2023 Revenue: ₹199.91 crores
- PAT: ₹21.73 crores in FY2023
- ROE: Estimated ROE over the last three years has been steadily increasing due to operational efficiencies.
Peer Comparison
In comparison to its peers in the engineering sectors:
- Market Cap: Estimated at ₹1 billion post-IPO
- PE Ratio: Approximately 18-22, competing favorably with a few industry leaders.
- ROE: Consistent year-over-year growth in ROE, outperforming several of its rivals in the sector.
Strengths
- Strong brand presence in the pharmaceutical engineering segments
- Robust customer relations and contract pipeline
- Innovative and adaptive approach in technical projects
Risks
- Heavy reliance on few major clients for revenue streams
- Market volatility impacting project bids and contracts
Expert Verdict
Market analysts view Fabtech Technologies as a promising IPO given its robust operational metrics and the growth potential in the pharmaceutical engineering domain.
Subscription Status
The subscription will open on 29 September and close on 03 October 2025. Investors can check real-time subscription rates on various financial websites.
Allotment & Listing Timeline
- Allotment Date: 05 October 2025
- Listing Date: 07 October 2025
FAQs
- When does the IPO open? The IPO opens on 29 September 2025.
- What is the issue size? The issue size is expected to be approximately ₹230 crores.
- How can I apply for the IPO? Investors can apply through registered brokers and fund houses.
How to Apply
Investors can apply for the Fabtech Technologies IPO through their trading accounts or by visiting [this link](https://www.kotaksecurities.com/ipo/fabtech-technologies-ltd-ipo/) for more information.
